Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Buy Note http://www.pcfg.co.uk/uploadDocuments/514_d_Hanson%20Westhouse-%2015%20December%2009.pdf
Overview * Continuing profitability for the six months ended 30 September 2009 of GBP121,474 despite the economic downturn * Balance Sheet strengthened by GBP1.4 million of new share capital and the repayment of loan stock * Total borrowings reduced by GBP8.2 million reflecting the Group's strong cash generation * Portfolio of receivables reduced by 6.1% to GBP154.8 million - which includes GBP27.5 million of unearned income to be released over the next three to four years * Loan loss charge steady at 4.6% (2009: 4.9%) * Supportive banks with committed facilities of GBP126 million * Strongly positioned for 2010, with reduced competition, attractive margins on new business and a well-collateralised portfolio
the massive spread???
Private & Commercial Finance Group: a discount too far? In the current days of the most severe recession to hit us in recent times business is challenging for everyone everywhere. It is easy to imagine that a small finance company would be finding the going particularly hard since the mounting cost and availability of funds is taking away whatever operating income is there. http://www.proactiveinvestors.co.uk/companies/news/9859/private-commercial-finance-group-a-discount-too-far-9859.html
You can deal well within the spread. It's a case of picking up the phone and asking. Here is the reason why people should look to do so http://www.pcfg.co.uk/investors/research_list.jsp Also all chart indicators have now turned positive.
Long may it continue
To tuck these away http://www.pcfg.co.uk/uploadDocuments/502_d_07%20Oct%2009%20-%20RNS%20Announcement.pdf
Last two days this has attracted some buying activity. I think we may have found the bottom.
and largwer trades now coming in. Worth a look at these levels.
Makes a nice change http://www.pcfg.co.uk/investors/research_list.jsp
Good news that the recent placing was oversubscribed. Buyers coming in now.
TIDMPCF RNS Number : 3696A Private & Commercial Fin Group Plc 07 October 2009 ? PCF.L / Index: AIM / Sector: Speciality & other finance 7 October 2009 Private & Commercial Finance Group plc ('PCFG' or 'the Group') Trading Statement The Directors of PCFG, the AIM quoted finance house, are pleased to provide an update on trading following the end of the half year on 30 September 2009. The Group's results for the six months ended 30 September 2009, which will be released on 15 December 2009, are anticipated to be in line with market expectations. CEO Scott Maybury said, "Our Group continues to demonstrate its considerable robustness in the financial services arena. With a strengthened balance sheet following the recently announced placing of new shares and redemption of the 2009 Convertible Loan Stock, we are well positioned for challenging economic conditions that we may encounter in 2010. We continue to benefit from reduced competition in our chosen sectors, which is enabling us to write good quality business on attractive terms and to support our customers and introductory sources." * * ENDS * *
Now to achieve the broker price targets.
PCF WH Ireland - Speculative Buy 13.5p http://www.pcfg.co.uk/uploadDocuments/494_d_WH%20I-%2010%20Sept%202009.pdf Hanson Westhouse - BUY http://www.pcfg.co.uk/uploadDocuments/495_d_Hanson%20Westhouse%20-%2014%20Sept%202009.pdf Could be worth a trade here.
I do hope so and any PI buying down here should be rewarded.
the plus today Buys - 145207 Sells - 8000 Lets see if the brokers notes end up on the money :)
Now people have noticed the tick higher buyers are moving in.
If this moves up then alot of people will be in for the ride.
Looks like people are starting to take note of the Broker note below and buyers are moving in on the PLUS market.
We can all make some easy money here.
With Daniel Stewart having a 20p target I think when this starts to move alot of people will be jumping on to capitalise on the rise and the rewards.